A harmonized and efficient clinical research environment would benefit patients and enhance European competitiveness

Authors

Abstract

Background. Implementation of the EU Regulation No. 536/2014 through national guidelines is a great opportunity to make sponsors reconsider Europe as a prime location for clinical trials.

Methods. In November 2014, a Panel of clinical researchers and representatives of the pharmaceutical industry, patient organisations and Italian regulatory agency discussed potential advances fostering Italian competitiveness in terms of clinical research. As a case study, this analysis of the Italian situation can be representative of the average European situation.

Results. Features characterising Italian clinical research patterns were analysed. Considerable engagement and cooperation by all stakeholders is required in addition to a well-structured interaction between National Authorities and ethical committees to comply with the strict timeframes mandated by the new Regulation.

Conclusions. In the Panel’s view, harmonisation of the approval process and strengthening of clinical site performance are mandatory to provide a good return on investment in Europe for the pharmaceutical industry, access for patients to innovative treatments and new resources for clinical sites.                                                                                                                                                                  

Share on

Downloads

Authors

Antonino Amato - Clinical Trial Center, Fondazione Policlinico Universitario A. Gemelli

Eugenio Aringhieri - Farmindustria-Gruppo Biotecnologico, Roma, Italia

Stefania Boccia - Istituto di Igiene della Facoltà di Medicina e Chirurgia “A. Gemelli” dell'Università Cattolica del Sacro Cuore, Roma, Italia

Filippo Buccella - EUPATI IT Chairman, Roma, Italia

Barbara Gorini - Investigator Site Development Lead, Development Operations, Global Clinical Trial Execution- Pfizer Italia, Roma, Italia

Donatella Gramaglia - Agenzia Italiana del Farmaco– AIFA, Roma, Italia

Riccardo Masetti - Dipartimento di Chirurgia Senologica, Policlinico Universitario A. Gemelli, Roma, Italia

Paolo Rossi - Dipartimento Pediatrico Universitario-Ospedaliero, Ospedale del Bambino Gesù– Università di Roma Tor Vergata, Roma, Italia

Pier Giuseppe Pellicci - Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, Milano, Italia

How to Cite
Amato, A., Aringhieri, E., Boccia, S., Buccella, F., Gorini, B., Gramaglia, D., Masetti, R., Rossi, P., & Pellicci, P. G. (2017). A harmonized and efficient clinical research environment would benefit patients and enhance European competitiveness. Annali dell’Istituto Superiore Di Sanità, 53(2), 104-107. Retrieved from https://annali.iss.it/index.php/anna/article/view/449
  • Abstract viewed - 384 times